SPOTLIGHT: Gemzar effective in cancer study


Eli Lilly's chemotherapy drug Gemzar was effective in delaying the recurrence of pancreatic cancer in a new study. Median disease-free survival time for volunteers taking Gemzar was 13.4 months compared to 6.9 months for the control group. Report